PP
ITCI
PFS Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-300
| Closed | -$39.6K | – | 522 |
|
|
2025
Q1 | $39.6K | Hold |
300
| – | – | 0.02% | 160 |
|
|
2024
Q4 | $25.1K | Hold |
300
| – | – | 0.01% | 198 |
|
|
2024
Q3 | $22K | Hold |
300
| – | – | 0.01% | 206 |
|
|
2024
Q2 | $20.5K | Hold |
300
| – | – | 0.01% | 196 |
|
|
2024
Q1 | $20.8K | Sell |
300
-212
| -41% | -$14.7K | 0.01% | 197 |
|
|
2023
Q4 | $36.7K | Hold |
512
| – | – | 0.03% | 143 |
|
|
2023
Q3 | $26.7K | Hold |
512
| – | – | 0.02% | 155 |
|
|
2023
Q2 | $32.4K | Hold |
512
| – | – | 0.03% | 146 |
|
|
2023
Q1 | $27.7K | Hold |
512
| – | – | 0.03% | 136 |
|
|
2022
Q4 | $27.1K | Hold |
512
| – | – | 0.03% | 133 |
|
|
2022
Q3 | $23.8K | Hold |
512
| – | – | 0.03% | 128 |
|
|
2022
Q2 | $29.2K | Hold |
512
| – | – | 0.03% | 114 |
|
|
2022
Q1 | $31.3K | Hold |
512
| – | – | 0.03% | 125 |
|
|
2021
Q4 | $26.8K | Buy |
+512
| New | +$26.8K | 0.02% | 140 |
|